If you have a bad experience after taking kratom, can medical professionals help?If you have a bad experience after taking kratom, can medical professionals help?
Alcohol And Drug Abuse – Johns Hopkins Medicine Podcasts
Eric Strain explains why standard hospital drug tests don’t usually detect kratom, despite a sharp increase in related emergency visits. The conversation highlights clinical decision-making without lab confirmation and raises concerns about synthetic compounds in products sold as kratom.
1:02•4 May 2026
Kratom, Hidden Risks, and Why Hospital Drug Tests May Miss It
Episode Overview
- Standard hospital drug tests do not routinely detect kratom or its main compounds, including mitragynine and 7-hydroxymitragynine.
- Emergency visits related to kratom use have increased significantly, yet no specific kratom screen is widely available.
- Clinicians often need to base their assessment on symptoms and clinical presentation rather than relying on lab tests.
- Many products marketed as kratom may contain synthetic 7-hydroxymitragynine, adding extra uncertainty and risk for consumers.
- Changing substance use patterns, including kratom and other drugs like xylazine, are outpacing traditional drug-testing panels.
“"We don't routinely test for kratom or mitragynine or 7-hydroxymitragynine. So our usual tests for drugs of abuse are really starting to become less relevant."”
How do people cope with the challenges of staying sober when new drugs appear faster than the tests that are meant to detect them? This short Johns Hopkins conversation looks at kratom and what actually happens if someone lands in A&E after taking it. Substance use disorder expert Eric Strain explains that standard drug screens simply don’t pick up kratom or its key compounds. As he puts it, "We don't routinely test for kratom or mitragynine or 7-hydroxymitragynine.
So our usual tests for drugs of abuse are really starting to become less relevant compared to what's being used out in the community." With emergency visits linked to kratom reportedly rising dramatically, that gap leaves doctors relying on symptoms and history rather than a handy lab result. Host Elizabeth Tracy keeps the pace brisk and clear, making the medical detail easy to follow even if you’re not a clinician.
Instead of dense jargon, you get a straightforward picture: many products sold as kratom now contain synthetic 7-hydroxymitragynine, and that raises serious questions about safety and predictability. Anyone using kratom, thinking about trying it, or supporting someone who does will hear a strong message of caution. You’ll also notice a wider theme running underneath the science: drug trends in the community are changing much faster than testing technology.
That’s crucial for people in recovery, families, and health professionals who may assume a “negative screen” means no substances are involved. If you’re curious about how doctors respond when a substance doesn’t show up on a test, or you’re worried about the risks of kratom specifically, this episode offers a clear, no-nonsense snapshot. It might leave you asking: how safe can a product be if even hospital tests don’t yet keep up with it?
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.